Dr. Mayes has received speaking fees (less than $10,000) from Actelion and book royalties (less than $10,000) from Oxford University Press.
Does C-Reactive Protein Predict the Long-Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?
Article first published online: 26 JUL 2013
Copyright © 2013 by the American College of Rheumatology
Arthritis Care & Research
Volume 65, Issue 8, pages 1375–1380, August 2013
How to Cite
Liu, X., Mayes, M. D., Pedroza, C., Draeger, H. T., Gonzalez, E. B., Harper, B. E., Reveille, J. D. and Assassi, S. (2013), Does C-Reactive Protein Predict the Long-Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?. Arthritis Care Res, 65: 1375–1380. doi: 10.1002/acr.21968
- Issue published online: 26 JUL 2013
- Article first published online: 26 JUL 2013
- Accepted manuscript online: 11 FEB 2013 10:07AM EST
- Manuscript Accepted: 18 JAN 2013
- Manuscript Received: 22 SEP 2012
- NIH/National Institute for Arthritis and Musculoskeletal and Skin Diseases. Grant Numbers: P50-AR-054144, K23-AR-061436
- NIH/Institute of Allergy and Infectious Diseases. Grant Numbers: U01-AI-09090, U01-AI-09090
- NIH. Grant Number: T32-AR-052283
- 7Canadian Scleroderma Research Group, , et al.Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.Arthritis Care Res (Hoboken)2012;64:1405–14., , , ,
- 13An R package for the joint modelling of longitudinal and time-to-event data.J Stat Soft2010;35:1–33..